Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians
Within-trial results of the Indian Diabetes Prevention Programme (IDPP)
Article Figures & Tables
Tables
- Table 1—
Components of expenditure considered for direct medical costs incurred during the intervention period of 3 years in various arms of the study
Item and provider Units (n/3 years) Time (h spent/3 years) Total cost in INR Control LSM Met LSM + Met Control LSM Met LSM + Met Control LSM Met LSM + Met Standard lifestyle cost 2,739 Expenditure—laboratories Drug cost 1,561 1,561 Visits 375 375 Physician 0 12 10 12 — 1.5 0.99 1.5 1,292 620 1,292 Social worker 4 12 7 12 0.83 2.25 0.66 2.25 47 504 93 504 Dietician 1 12 1 12 0.16 2.25 0.33 2.25 10 531 20 531 Helper 1 12 5 12 0.16 1.5 0.58 1.5 9 336 65 336 Technician 0 6 8 6 — 0.48 0.48 0.48 60 75 60 Phone calls Social worker 1 39 10 39 0.05 1.98 0.24 1.98 3 745 33 745 Dietician 0 39 0 39 — 1.98 — 1.98 777 — 777 Helper 2 0 48 0 0.10 — 0.41 — 6 — 263 — Secretary 3 36 36 72 0.15 0.15 0.25 0.15 6 78 78 156 Overhead charges 813 900 846 894 Travel cost 1,845 4,913 3,113 4,913 Total INR (U.S. $) 2,739 (61) 10,136 (225) 9,881 (220) 12,144 (270) -
Met, metformin.
-
- Table 2—
Summary of the total and incremental costs of the interventions of IDPP and sensitivity analysis with hypothetical models
Type of intervention Cost of intervention Control LSM Met LSM + Met 1st year 939 (21) 3883 (86) 3,568 (79) 4,571 (102) 2nd year 900 (20) 2594 (58) 3,069 (68) 3,254 (72) 3rd year 900 (20) 3659 (81) 3,244 (72) 4,319 (96) Total 2,739 (61) 10,136 (225) 9,881 (220) 12,144 (270) No. needed to prevent one case of diabetes (NNT) — 6.4 6.9 6.5 Incremental cost (IC) — 7,397 (164) 7,142 (159) 9,405 (209) CER: IC × NNT — 47,341 (1,052) 49,280 (1,095) 61,133 (1,359) Sensitivity analysis (CER) No physician, effectiveness 10% less 42,979 (955) 49,176 (1,093) 57,927 (1,287) Group sessions, effectiveness same 37,670 (837) 47,886 (1,064) 51,311 (1,140) Group sessions, effectiveness 10% more 33,903 (753) 43,444 (965) 46,259 (1,028) -
Data are INR (U.S. $). CER, cost-effectiveness ratio; Met, metformin.
-